Amit Gupta Sells 52,049 Shares of Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 52,049 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $0.90, for a total value of $46,844.10. Following the transaction, the chief executive officer owned 704,803 shares in the company, valued at approximately $634,322.70. This trade represents a 6.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Amit Gupta also recently made the following trade(s):

• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total transaction of $41,997.87.
• On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total transaction of $6,794.19.

Cardlytics Trading Down 4.8%

Shares of NASDAQ:CDLX opened at $0.89 on Friday. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.14 and a current ratio of 1.14. The stock’s 50-day moving average is $1.09 and its 200-day moving average is $1.40. The company has a market cap of $47.91 million, a P/E ratio of -0.42, a P/E/G ratio of 0.15 and a beta of 1.03. Cardlytics, Inc. has a 52-week low of $0.80 and a 52-week high of $3.28.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Wall Street Zen cut Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Three research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $2.25.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC acquired a new stake in Cardlytics during the third quarter worth $26,000. Catalyst Funds Management Pty Ltd acquired a new stake in shares of Cardlytics during the 2nd quarter valued at about $32,000. Sand Hill Global Advisors LLC bought a new stake in Cardlytics in the second quarter valued at about $35,000. Y Intercept Hong Kong Ltd acquired a new position in Cardlytics in the second quarter worth about $42,000. Finally, Qube Research & Technologies Ltd acquired a new position in Cardlytics in the third quarter worth about $55,000. 68.10% of the stock is owned by institutional investors.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.